These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6091062)

  • 1. The pyrophosphate heart scintigram in children with progressive muscular dystrophy.
    Duska F; Nesvadba Z; Zdánský P; Novák J; Kubícek J; Kafka P; Vizda J; Mazurová Y
    Nuklearmedizin; 1984 Aug; 23(4):189-91. PubMed ID: 6091062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary study of serum enzymology in Duchenne muscular dystrophy].
    Wu KM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):342-5. PubMed ID: 3836825
    [No Abstract]   [Full Text] [Related]  

  • 4. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T; Annaka S; Baba T; Kanno M
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis of occult muscular dystrophy: importance of the "chance" finding of elevated serum aminotransferase activities.
    Morse RP; Rosman NP
    J Pediatr; 1993 Feb; 122(2):254-6. PubMed ID: 8429443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
    Eriksson P; Backman C; Bjerle P; Eriksson A; Holm S; Olofsson BO
    Br Heart J; 1984 Sep; 52(3):321-6. PubMed ID: 6087862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular dystrophy. Part II: Serum enzymes in relatives of cases of the Duchenne muscular dystrophy.
    Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
    Indian J Med Res; 1974 Apr; 62(4):605-11. PubMed ID: 4435869
    [No Abstract]   [Full Text] [Related]  

  • 11. The sensitivity of scintigraphic myocardial imaging by the use of 99mTc-labelled pyrophosphate in the diagnosis of cardiomyopathy of various etiology.
    Duska F; Vizda J; Kubícek J; Kafka P; Nesvadba Z; Zdánský P; Bastecký J
    Eur J Nucl Med; 1979 Apr; 4(2):87-90. PubMed ID: 227692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 13. Poikiloderma atrophicans vasculare associated with muscular dystrophy.
    Woolfson H; McQueen A
    Arch Dermatol; 1973 Jan; 107(1):115-7. PubMed ID: 4682534
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids.
    Ohman EM; Teo KK; Johnson AH; Collins PB; Dowsett DG; Ennis JT; Horgan JH
    Br Med J (Clin Res Ed); 1982 Nov; 285(6354):1523-6. PubMed ID: 6814629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of myocardial infarct after cardiac surgery using technetium scintigraphy. Apropos of 106 cases].
    Brodaty D; Teboul B; Akerman M; Dubois C; Liebeaux M; Dhainaut JF; Bachet J; Goudot B; Guilmet D
    Arch Mal Coeur Vaiss; 1982 Feb; 75(2):137-45. PubMed ID: 6280632
    [No Abstract]   [Full Text] [Related]  

  • 16. Muscular dystrophy. Part I: Serum enzymes in the Duchenne muscular dystrophy and other neuromuscular disorders.
    Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
    Indian J Med Res; 1974 Apr; 62(4):598-604. PubMed ID: 4435868
    [No Abstract]   [Full Text] [Related]  

  • 17. [The importance of the current use of pyrophosphate scintigraphy and other noninvasive methods in the detection of cardiac damage in systemic lupus erythematosus].
    Duska F; Bradna P; Pospísil M; Kubícek J; Vizda J; Kafka P; Palicka V; Mazurová Y
    Cas Lek Cesk; 1986 Sep; 125(38-39):1216-9. PubMed ID: 3022930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pyrophosphate scan of the heart in cardiomyopathies (author's transl)].
    Duska F; Novák J; Kubícek J; Vizda J; Kafka P; Blaha V; Nesvadba Z; Zdánský P
    Cesk Radiol; 1982 Jan; 36(1):40-7. PubMed ID: 6284387
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum enzyme alterations in neuromuscular disorders.
    Munsat TL; Baloh R; Pearson CM; Fowler W
    JAMA; 1973 Dec; 226(13):1536-43. PubMed ID: 4800933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Echography and scintigraphy using technetium 99m pyrophosphate in the diagnosis of cardiac amyloidosis].
    Guy JM; Lamaud M; Segura C; Berthaud T; Duranton B; Verneyre H
    Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):215-8. PubMed ID: 2544133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.